Patent · US Active

Baculoviruses with enhanced virion production and a method for the production of baculoviruses

US8703469B2 · kind B2 · utility

0Cited by
5References
23Claims
0Family size

Assignees

Inventors

Key dates

Filing dateSep 13, 2011
Grant dateApr 22, 2014
Priority date
Expiry dateSep 13, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2810/6081
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A method of co-expressing a portion of the VSV G protein gene or a truncated “stem” portion with GP64 and a retrovirus increases the titer of retroviral vectors. A truncated VSV G protein, preferably comprised of a small segment from the C-terminal portion of the ectodomain plus the transmembrane (TM) and cytoplasmic tail (CTD) domains of VSV G, co-expressed with retroviral vectors, enhances the production titers of the retroviral vectors. A preferred embodiment uses a VSV G construct that includes an N-terminal c-Myc epitope plus 42 amino acids from the C-terminal portion of the ectodomain, 20 amino acids from the predicted TM domain, and 29 amino acids from the predicted CTD of the VSV G protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.